Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alrgn Bio

Alrgn Bio
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$946K LATEST DEAL AMOUNT
1 INVESTORS
Description

Operator and owner of a food bioprocessing company providing hypoallergenic peanuts. The company combines its patented food grade enzymatic process with current food industry processing equipment to inactivate peanut allergens.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Primary Office
  • 2901 E Gate City Boulevard
  • Suite 2400
  • Greensboro, NC 27401
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Alrgn Bio’s full profile, request a free trial.

Alrgn Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 16-Dec-2016 $946K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Alrgn Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Aubrey Capital Venture Capital Minority 000 0000 000000 0

Alrgn Bio Executive Team (4)

Name Title Board
Seat
Contact
Info
Kit McQuiston Chief Executive Officer, Promoter & Board Member

3 Former Executives

You’re viewing 1 of 4 executives. Get the full list »

Alrgn Bio Board Members (1)

Name Representing Role Since Contact
Info
Kit McQuiston Alrgn Bio Chief Executive Officer, Promoter & Board Member 000 0000